FMS Stock Analysis: Buy, Sell, or Hold?
FMS - Fresenius Medical Care AG
$23.70
0.31 (1.33%)
▲
5d:
+1.07%
30d:
+5.33%
90d:
+8.22%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Get Alerted When FMS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: FMS shows positive signals but monitor for confirmation. Market pricing in 0.2% growth. Moderate conviction.
💡 BUY OPPORTUNITY: FMS shows positive signals but monitor for confirmation. Market pricing in 0.2% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$45.41
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$28.20
15.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FMS is currently trading at $23.70, which is considered extended relative to its 30-day fair value range of $21.36 to $23.13. The stock's valuation (Forward PE: 6.9) is in line with its historical norms (6.9). At these levels, the market is pricing in 0.2% annual earnings growth.
Technical Outlook: Technically, FMS is in a downtrend. The price is approaching resistance at $22.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FMS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FMS is in a downtrend. The price is approaching resistance at $22.50. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: FMS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.36 -
$23.13
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($25.51)
- BULLISH: Expecting earnings turnaround to 0.2% growth with -5.5% revenue growth
Trading Range Analysis
30-Day Trading Range
$21.36 -
$23.13
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.55
Resistance Level
$22.50
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.92
Wall Street Target
$25.51
(+9.1%)
Revenue Growth (YoY)
-5.5%
Earnings Growth (YoY)
-17.1%
Profit Margin
4.9%
Valuation Premium vs History
+0.2% premium
PE vs Historical
6.9 vs 6.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.2%
(market-implied from PE analysis)
1-Year Target
$23.44
(+0%)
2-Year Target
$23.48
(+0%)
3-Year Target
$23.53
(+1%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
PE COMPRESSION
$23.46
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 32.3%)
$170.45
(+629%)
Base:
(SPY PE: 6.9, Growth: 32.3%)
$54.16
(+132%)
Bear:
(PE: 5.9, Growth: 32.3%)
$46.04
(+97%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (12x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 12.42 | Current EPS (TTM): $1.90
Bull Case
$46.16
(+97%)
Analyst growth 77.9%, PE expands to 13.7
Base Case
$41.96
(+79%)
Market implied 77.9%, PE stable at 12.4
Bear Case
$16.04
(-31%)
Severe decline -20.0%, PE contracts to 10.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 23, 2026 4:42 PM ET
Data refreshes hourly during market hours. Next update: 5:42 PM
Data refreshes hourly during market hours. Next update: 5:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FMS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
